PDZD7 Antibody - C-terminal region
Rabbit Polyclonal Antibody
- 产品详情
- 实验流程
Application ![]()
| WB |
---|---|
Primary Accession | Q9H5P4 |
Other Accession | NM_024895, NP_079171 |
Reactivity | Human, Mouse, Rat, Rabbit, Guinea Pig, Horse, Bovine |
Predicted | Human, Mouse, Rat, Rabbit, Pig, Guinea Pig, Horse, Bovine |
Host | Rabbit |
Clonality | Polyclonal |
Calculated MW | 111752 Da |
Gene ID | 79955 |
---|---|
Alias Symbol | PDZK7 |
Other Names | PDZ domain-containing protein 7, PDZD7, PDZK7 |
Format | Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
Reconstitution & Storage | Add 50 ul of distilled water. Final anti-PDZD7 antibody concentration is 1 mg/ml in PBS buffer with 2% sucrose. For longer periods of storage, store at 20°C. Avoid repeat freeze-thaw cycles. |
Precautions | PDZD7 Antibody - C-terminal region is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | PDZD7 (HGNC:26257) |
---|---|
Function | In cochlear developing hair cells, essential in organizing the USH2 complex at stereocilia ankle links. Blocks inhibition of adenylate cyclase activity mediated by ADGRV1. |
Cellular Location | Cell projection, cilium. Nucleus Cell projection, stereocilium {ECO:0000250|UniProtKB:E9Q9W7} Note=Localizes at the ankle region of the stereocilia {ECO:0000250|UniProtKB:E9Q9W7} |
Tissue Location | Weakly expressed in the inner ear. Expressed in the retinal pigment epithelium. |
Research Areas
For Research Use Only. Not For Use In Diagnostic Procedures.
Application Protocols
Provided below are standard protocols that you may find useful for product applications.
REFERENCES
Ebermann I.,et al.J. Clin. Invest. 120:1812-1823(2010).
Ota T.,et al.Nat. Genet. 36:40-45(2004).
Deloukas P.,et al.Nature 429:375-381(2004).
Schneider E.,et al.Hum. Mol. Genet. 18:655-666(2009).
Mayya V.,et al.Sci. Signal. 2:RA46-RA46(2009).

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.